Jefferies Group acquired 600 Thousand Aerovate Therapeutics shares worth $1.66 Million. That's 0.02% of their equity portfolio (444th largest holding). The investor owns 2.08% of the outstanding Aerovate Therapeutics stock. The stake costed the investor $1.48 Million, netting the investor a gain of 12% so far.